Effectiveness of a unique antispasmodic 3,4-dihydro-5-phenoxybenzo (b) (1,7)naphthyridin-1(2H)-one eu-1086, in vivo and in vitro.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D004285:Dogs; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007420:Intestine, Large / Q000187:drug effects; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009287:Naphthyridines / Q000008:administration & dosage / Q000494:pharmacology*; D010276:Parasympatholytics / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology
D009287:Naphthyridines; D010276:Parasympatholytics; D012701:Serotonin; C005539:EU-1086; D006632:Histamine; D000109:Acetylcholine